Fonte: Leukemia Research. Unidade: FM
Assuntos: LINFOMA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Juliana et al. Modified magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. Leukemia Research, v. 30, n. 6, p. 681-685, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2005.10.002. Acesso em: 04 nov. 2024.APA
Pereira, J., Belesso, M., Pracchia, L. F., Hallack Neto, A. E., Beitler, B., Macedo, M. C. M. de A., et al. (2006). Modified magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. Leukemia Research, 30( 6), 681-685. doi:10.1016/j.leukres.2005.10.002NLM
Pereira J, Belesso M, Pracchia LF, Hallack Neto AE, Beitler B, Macedo MCM de A, Dias LCS, Llacer PED, Dulley FL, Chamone D. Modified magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil [Internet]. Leukemia Research. 2006 ; 30( 6): 681-685.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2005.10.002Vancouver
Pereira J, Belesso M, Pracchia LF, Hallack Neto AE, Beitler B, Macedo MCM de A, Dias LCS, Llacer PED, Dulley FL, Chamone D. Modified magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil [Internet]. Leukemia Research. 2006 ; 30( 6): 681-685.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.leukres.2005.10.002
